Group 1 - The company, Huajian Medical (01931.HK), announced a voluntary plan to purchase cryptocurrency, specifically aiming to strengthen its Ethereum (ETH) reserves and accelerate the development of the ivd.xyz exchange ecosystem [1][2] - The board of directors seeks shareholder approval to grant purchasing authority for potential cryptocurrency acquisitions, with a total purchase limit not exceeding HKD 3 billion over a period of 36 months [1][2] - The board believes that the potential cryptocurrency purchases align with the company's long-term development strategy and overall shareholder interests, providing necessary flexibility to capture opportunities in a rapidly changing market [2] Group 2 - Ethereum (ETH), launched in 2014, is the second-largest cryptocurrency by market capitalization, following Bitcoin [2] - The authorization for purchasing cryptocurrency is seen as a crucial component of the company's asset allocation strategy, aimed at building a global intellectual property trading hub for innovative drugs and supporting the international expansion of national innovative drugs [2] - The company emphasizes its long-term vision of benefiting the country, the public, and the world through these strategic initiatives [2]
华检医疗(01931.HK)拟购买加密货币 总金额不超30亿港元